Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life's unique antibody fragment-based platform   Agreement provides potential for up to approx.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

BostonGene, developer of the leading AI foundation model for cancer and the immune system, today announced that it will showcase its latest advances at the Association for Molecular Pathology (AMP) ...

This is just one of the grisly examples given in The Atlas Of Deadly Plants, a tome of toxic tales by expert gardener, ...

Advancements in research and ongoing clinical trials related to HDFN prevention and treatment can change HDFN care for the ...

Optigo Biotherapeutics (“Optigo”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its ...

Rising temperatures and erratic rainfall have supercharged the breeding of sandflies that spread the climate-driven disease ...

All across the region this year, lilacs were affected by a fungal disease called pseudocercospora, which got its start during ...

Marius Pharmaceuticals, Inc., today announced the formation of an all-female advisory board to advance the company’s efforts in addressing the significant unmet ...

Many diseases spread fast through touch, watering, or even wind. Move the suspicious plant away and treat it separately. Sometimes it’s nothing, but being cautious can save your whole collection from ...

CLEVELAND — With fall festivities underway, it means Halloween is right around the corner. So when is your community having its 2025 trick-or-treat? Below is an extensive alphabetical guide to local ...